Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorThe Second Hospital of Shandong University
About this trial
Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer.
Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Enhanced Recovery After Surgery (ERAS )
Procedure/Surgerythe treatment of procedure according to Guidelines for enhanced recovery after lung surgery: recommendations of the ERAS Society and the ESTS
Traditional perioperative management without Enhanced Recovery After Surgery (ERAS )
Procedure/Surgerythe treatment of procedure not abiding Guidelines for enhanced recovery after lung surgery
Treatment groups
350 Participants
are divided into 2 treatment groupsGroup A: ERAS- GroupExperimental treatment 1 intervention
Group B: Control- GroupOther 1 intervention
Trial outcomes
Primary outcomes
1
intensive care unit utilization
the time in intensive care unit utilization
Time frame
within 4 days after surgery2
the degree of pain
Visual Analogue Scale/Score
Time frame
within 4 days after surgery3
the time of ambulation
the time after surgery that patients could leave the bed and walk
Time frame
within 48 hours after surgery4
the time for oral feed
the time for oral feed
Time frame
within 48 hours after surgerySecondary outcomes
1
disease- free survival
disease- free survival
Time frame
within 5 years after surgery2
overall survival
overall survival
Time frame
within 10 years after surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov